Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Baclofen 💬[1] Baclofen[1] Baclofen[2] GABBR,
GABBR 💬
[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[7] 2, 10, 13, 18, 65, 149, 206 💬
2 Botulinum toxin type A 💬[1] Botulinum toxin type A[5] Botulinum toxin A; Botulinum toxin type A; BTX-A; Incobotulinumtoxina; Onabotulinumtoxina[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[13] 2, 5, 6, 7, 13, 15, 17, 47, 51, 113, 149, 171, 226 💬
3 Brivaracetam 💬[1] Brivaracetam[1] Brivaracetam[1] SV2 💬 [1] ECM-receptor interaction 💬[2] 149, 309 💬
4 Charcoal, activated 💬[1] Activated charcoal[2] Activated charcoal; Carbon--[6] 6, 13, 85, 97, 149, 235 💬
5 Ezetimibe 💬[1] Ezetimibe[1] Ezetimibe[1] NPC1L1 💬 [1] Fat digestion and absorption 💬[4] 79, 93, 149, 260 💬
6 Fenfluramine 💬[1] Fenfluramine[2] Fenfluramine; Fenfluramine hydrochloride[5] HTR1,
HTR2,
HTR2,
SIGMAR1,
SLC6A4 💬
[11] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[4] 140, 144, 145, 149 💬
7 Fenfluramine hydrochloride 💬[1] Fenfluramine[2] Fenfluramine; Fenfluramine hydrochloride[5] HTR1,
HTR2,
HTR2,
SIGMAR1,
SLC6A4 💬
[11] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[4] 140, 144, 145, 149 💬
8 Lacosamide 💬[1] Lacosamide[1] Lacosamide[2] SCN3A,
SCN9A 💬
[1] Taste transduction 💬[4] 2, 46, 149, 298 💬
9 Levetiracetam 💬[1] Levetiracetam[1] Levetiracetam[1] SV2 💬 [1] ECM-receptor interaction 💬[7] 2, 4, 6, 13, 34, 149, 307 💬
10 Melatonin 💬[1] Melatonin[1] Melatonin[2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[16] 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
11 Oxygen 💬[1] Oxygen[1] Oxygen--[13] 22, 49, 70, 85, 86, 88, 149, 168, 235, 271, 298, 299, 330 💬
12 Padsevonil 💬[1] Padsevonil[1] Padsevonil[3] SV2,
SV2,
SV2 💬
[1] ECM-receptor interaction 💬[1] 149 💬
13 Prabotulinumtoxin A 💬[1] Botulinum toxin type A[5] Botulinum toxin A; Botulinum toxin type A; BTX-A; Incobotulinumtoxina; Onabotulinumtoxina[1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[13] 2, 5, 6, 7, 13, 15, 17, 47, 51, 113, 149, 171, 226 💬
14 Sodium oxybate 💬[1] Sodium oxybate[1] Sodium oxybate--[2] 6, 149 💬
15 Tocilizumab 💬[1] Tocilizumab[1] Tocilizumab[1] IL6R 💬 [11] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[24] 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
16 Triheptanoin 💬[1] Triheptanoin[1] Triheptanoin--[10] 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 💬